Streamlining Hematology Prior Auth with SMART on FHIR
Klivira's platform delivers robust hematology SMART on FHIR prior auth capabilities, integrating directly into your EMR to automate complex authorization processes for blood disorders and cancers.
For revenue cycle directors, prior authorization coordinators, and IT integration leads, the intersection of specialized hematology treatments and manual PA processes presents significant operational challenges. High-cost therapies, complex documentation, and frequent payer policy updates demand an integrated, efficient solution. Klivira leverages SMART on FHIR to embed prior authorization directly within the clinical workflow, mitigating context-switching and manual data entry.
The Challenge of Hematology Prior Authorization
Hematology prior authorization involves a range of high-cost, high-complexity treatments, including factor concentrates for hemophilia, specialty drugs for sickle cell disease, advanced imaging for MM/MGUS workup, and CAR-T cell therapies. These categories are frequently subject to stringent payer criteria, often requiring detailed documentation per ASH guidelines and NCCN for hematologic oncology, leading to significant administrative burden and potential delays in patient care.
Key PA Triggers in Hematology
- **Hematologic Oncology:** Biologics and chemotherapies for lymphomas, leukemias, multiple myeloma, including CAR-T cell therapies (e.g., Yescarta, Kymriah).
- **Hemophilia Factor Concentrates:** Factor VIII and IX products (e.g., Advate, Hemlibra) for prophylaxis and on-demand treatment.
- **Sickle Cell Disease Therapeutics:** Specialty drugs such as voxelotor (Oxbryta) and crizanlizumab (Adakveo), and gene therapies.
- **VTE/Anticoagulation Specialty Drugs:** Direct Oral Anticoagulants (DOACs) in specific clinical scenarios.
- **Bone Marrow / Stem Cell Transplant:** Autologous and allogeneic transplant procedures.
Transforming Workflows with SMART on FHIR in Hematology
Implementing a SMART on FHIR-launched PA application fundamentally changes the prior authorization workflow for hematology. Instead of clinicians or coordinators exiting the EMR to manage authorizations, Klivira launches directly from within systems like Epic Hyperspace/Hyperdrive, Cerner PowerChart, athenaOne, or MEDITECH Expanse. This integration eliminates context-switching and manual data transfer, leveraging SMART App Launch and OAuth 2.0 for seamless, secure access with patient and encounter context delivered automatically.
Automated Context and Documentation via FHIR R4
Klivira's SMART on FHIR integration reads US Core resources directly from the EMR's FHIR endpoint, capturing essential clinical context without screen-scraping or manual retyping. For complex hematology cases, this means critical documentation—such as factor levels, joint health, bleeding episode tracking for hemophilia, or prior-line therapy details for CAR-T—is automatically assembled. This direct data access ensures accuracy and completeness, addressing common denial reasons related to documentation gaps.
Integrated PA Submissions and Status Updates
Within the SMART-launched application, Klivira executes the full Da Vinci stack, including Coverage Requirements Discovery (CRD), Documentation Templates and Rules (DTR) for automated form population, and Prior Authorization Support (PAS) for submission. Once a decision is rendered, outcomes are written back to the EMR as structured FHIR resources (DocumentReference, Communication, Task), replacing inconsistent free-text notes and providing queryable PA status data directly within the patient's chart.
Klivira's Specialized Support for Hematology
Klivira’s platform incorporates ASH/NCCN-aware policy logic, specifically designed for hematologic conditions. This includes detailed utilization tracking for hemophilia factor concentrates, automation of CAR-T eligibility documentation, and streamlined workflows for bone marrow/stem cell transplant prior authorizations. Our solution adapts to the unique requirements of hematology, ensuring that even the most complex cases receive precise and timely authorization support.
Frequently asked questions
How does SMART on FHIR specifically benefit hematology prior authorizations?
SMART on FHIR significantly benefits hematology by embedding the PA workflow directly into the EMR. This eliminates context-switching for clinicians, automates the transfer of patient and encounter data, and facilitates the structured retrieval of critical clinical documentation (e.g., factor levels, NCCN criteria for oncology) via FHIR R4. This reduces manual errors and accelerates approval times for high-cost hematology treatments.
Which EMR systems support SMART on FHIR for hematology PA workflows?
Klivira's SMART on FHIR integration is compatible with major EMR systems that support SMART App Launch, including Epic (Hyperspace/Hyperdrive), Cerner (PowerChart), athenahealth (athenaOne), and MEDITECH (Expanse). These platforms provide the necessary FHIR endpoints for secure data exchange and application launching, ensuring broad applicability across health systems managing hematology patients.
Can Klivira handle the specific documentation requirements for CAR-T cell therapies in hematology?
Yes, Klivira's platform is designed to automate the documentation assembly for CAR-T cell therapies. Leveraging FHIR R4, it can pull necessary clinical context such as diagnosis confirmation and prior-line therapy documentation directly from the EMR, aligning with NCCN guidelines and addressing common eligibility-related denial reasons specific to these advanced treatments.
How does Klivira address common denial reasons for hemophilia factor concentrates?
Klivira incorporates ASH-aware policy logic and hemophilia factor utilization tracking to address denial reasons such as prophylaxis-vs-on-demand criteria. By automating the collection and presentation of relevant clinical data—like factor levels, joint health, and bleeding episode tracking—the platform helps ensure that submissions meet payer requirements upfront, reducing the likelihood of denials.
Is the PA status written back to the EMR in a structured format?
Yes, Klivira's SMART on FHIR integration ensures that prior authorization decisions and status updates are written back to the EMR as structured FHIR resources. This includes DocumentReference for decision letters, Communication for status updates, and Task resources for follow-up, where supported by the EMR's write surface. This replaces free-text notes with queryable, consistent data within the patient's chart.
Related coverage
Other hematology prior auth workflows
- Automating Hematology Inpatient Admission Prior Auth
- Optimizing Hematology AIM Specialty Health Integration for Prior Authorization
- Optimizing Hematology Availity Integration for Prior Authorization
- Optimizing Hematology Biologics Prior Auth Workflows
- Optimizing Hematology CVS Caremark Integration for Complex Prior Authorizations
- Optimizing Hematology Prior Authorizations with Change Healthcare Clearinghouse
- Automated Hematology Claim Status Tracking for Complex Therapies
- Achieving Hematology CMS-0057-F Compliance in Prior Authorization Workflows
- Optimizing Hematology CoverMyMeds Integration for Specialty Drug Prior Authorization
- Streamlining Hematology Prior Authorization with Da Vinci PAS
- Streamlining Hematology Denial Appeal Automation
- Streamlining Hematology Denial Management with Klivira
- Streamlining Hematology Eligibility Verification for Complex Blood Disorders
- Streamlining Hematology ePA via NCPDP SCRIPT for Specialty Therapies
- Streamlining Hematology eviCore Integration for Advanced Therapies
- Streamlining Hematology Express Scripts Integration for Complex Therapies
- Automating Hematology GLP-1 Prior Auth: Precision for Complex Cases
- Streamlining Hematology Imaging Prior Auth for Advanced Diagnostics
- Streamlining Hematology Carelon Prior Authorizations
- Optimizing Hematology NIA Magellan Integration for Prior Authorization
- Accelerating Hematology Oncology Pathways Prior Auth for Complex Regimens
- Optimizing Hematology Prior Authorization with OptumRx Integration
- Optimizing Hematology Payer Portal Automation for Complex Therapies
- Streamlining Hematology Prior Authorization Automation
- Automating Hematology Specialty Drug Prior Auth
- Automating Hematology 7-Day Urgent Prior Auth Workflows
- Optimizing Hematology Prior Authorizations with Waystar Clearinghouse
- Automating Hematology X12 278 Prior Auth for Complex Therapies
Ready to automate this workflow for this specialty?
See how Klivira automates prior authorizations for your team.
Request a demo